Cytokinetics, Inc. (CYTK)
73.26
-0.69
(-0.93%)
USD |
NASDAQ |
Sep 04, 10:13
Cytokinetics Cash and Short Term Investments (Annual) : 885.34M for Dec. 31, 2025
Cash and Short Term Investments (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 885.34M |
| December 31, 2024 | 1.076B |
| December 31, 2023 | 615.20M |
| December 31, 2022 | 782.58M |
| December 31, 2021 | 471.64M |
| December 31, 2020 | 464.06M |
| December 31, 2019 | 225.11M |
| December 31, 2018 | 198.73M |
| December 31, 2017 | 268.89M |
| December 31, 2016 | 156.25M |
| December 31, 2015 | 111.44M |
| December 31, 2014 | 83.23M |
| December 31, 2013 | 77.73M |
| Date | Value |
|---|---|
| December 31, 2012 | 74.00M |
| December 31, 2011 | 49.02M |
| December 31, 2010 | 71.64M |
| December 31, 2009 | 114.73M |
| December 31, 2008 | 56.87M |
| December 31, 2007 | 119.74M |
| December 31, 2006 | 109.54M |
| December 31, 2005 | 76.21M |
| December 31, 2004 | 105.70M |
| December 31, 2003 | 121.72M |
| December 31, 2002 | 26.81M |
| December 31, 2001 | 58.17M |
| December 31, 2000 | 56.79M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| Bristol Myers Squibb Co. | 10.67B |
| Krystal Biotech, Inc. | 827.79M |
| Ionis Pharmaceuticals, Inc. | 2.677B |
| Vertex Pharmaceuticals, Inc. | 6.611B |
| Alnylam Pharmaceuticals, Inc. | 2.908B |